1.
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.
2.
3.
4.
5.
6.
7.
8.
Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (Acta Neurologica Belgica, (2018), 118, 1, (7-11),...
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus